Awardee OrganizationMASSACHUSETTS INSTITUTE OF TECHNOLOGY
Description
Abstract Text
DESCRIPTION (Adapted from Applicant's Abstract)
The hemostatic balance is regulated by vascular bed-specific endothelial cell
signaling pathways. The applicants propose that coronary artery thrombosis
arises through local alterations in one or more of these pathways. The overall
goals of the Collaborative Program are to elucidate the molecular basis of
endothelial cell subtype-specific gene expression in the heart and to identify
the critical components of cardiac hemostasis. In this project , Dr. Rosenberg
will study the role of a platelet-derived growth factor signaling pathway in
mediating expression of a gene program within cardiac microvascular
endothelial cells that includes tissue factor (TF). He will also optimize a
recently developed mouse model of coronary artery thrombosis. In this project,
Dr. Aird will examine the role of the Egr-l transcription factor in mediating
cardiac-specific hemostasis. He will ask how a single gene can serve to "fine
tune" hemostasis according to the local needs of the tissue. In this project, Dr.
Mackman will evaluate the role of a thrombin-PAR-1 signaling pathway in
governing local levels of procoagulant (TF) and fibrinolytic (tissue-type
plasminogen activator) molecules within the heart. In addition, he will
address the contribution of monocytederived TF to cardiac hemostasis. In this
project, Dr. Housman will use genetic approaches in large populations to
identify genotypes which significantly contribute to coronary thrombosis. The
three basic science projects are interrelated by several common
themes. Each component involves: (1) the study of a cardiac endothelial cell
type-specific signaling pathway, (2) the determination of the effects of cell
type-specific signaling pathways on global hemostasis (fibrin deposition) (3)
the study of TF gene regulation and its role as the initiator of coagulation
in the cardiac circulation, and (4) the use of transgenic mouse technology for
studying vascular-bed specific hemostasis in the heart. The clinical project
will serve as a vital link to validate the role of local hemostatic components in
human populations.
No Sub Projects information available for 5R01HL065230-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL065230-03
Patents
No Patents information available for 5R01HL065230-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL065230-03
Clinical Studies
No Clinical Studies information available for 5R01HL065230-03
News and More
Related News Releases
No news release information available for 5R01HL065230-03
History
No Historical information available for 5R01HL065230-03
Similar Projects
No Similar Projects information available for 5R01HL065230-03